BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR) - Net Asset Value(s)
December 21, 2012 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} BOUSSARD &...
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP) - Net Asset Value(s)
December 21, 2012 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} BOUSSARD...
Karolinska Development Announces a SEK 220 million Strategic Deal
December 21, 2012 01:30 ET
|
Karolinska Development AB
STOCKHOLM – December 21, 2012. Karolinska Development AB announced today that a
syndicate led by the life science investor Rosetta Capital Limited (“Rosetta”)
will acquire a minority share in...
Karolinska Development gör en strategisk affär värd 220 miljoner kronor
December 21, 2012 01:30 ET
|
Karolinska Development AB
STOCKHOLM den 21 december 2012. Karolinska Development AB tillkännager i dag att
ett syndikat under ledning av Rosetta Capital Limited (Rosetta), en investerare
inom life science, kommer att förvärva...
Net Entertainment launches Live Casino with two beta customers
December 21, 2012 01:30 ET
|
NetEnt AB
Net Entertainment is proud to announce that it’s Live Casino roulette is live with two customers for beta testing. Additional operators will be launched gradually going forward.
For...
Prothena Begins Trading on NASDAQ Global Market Under Symbol "PRTA"
December 21, 2012 01:30 ET
|
Prothena Corporation plc
DUBLIN, Ireland, Dec. 21, 2012 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a biotechnology company focused on the discovery and development of novel antibodies for the potential...
Novartis drug Exjade® approved by European Commission for iron overload in patients with non-transfusion-dependent thalassemia
December 21, 2012 01:15 ET
|
Novartis Pharma AG
Exjade is the first oral treatment approved in the EU for chronic iron overload in patients with non-transfusion-dependent thalassemia (NTDT) syndromes Pivotal placebo-controlled study data show...
Teck Provides Update on Coal Shipments
December 21, 2012 00:33 ET
|
Teck Resources Limited
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 21, 2012) - Teck Resources Limited (TSX: TCK.A and TCK.B, NYSE: TCK) ("Teck") announced today that coal sales for the fourth quarter of...
Rosen Law Firm Files Class Action Against Envivio, Inc. and Announces Important Investor Deadline -- ENVI
December 20, 2012 22:54 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 20, 2012 (GLOBE NEWSWIRE) -- The Rosen Law Firm announces it has filed a class action against Envivio, Inc. (Nasdaq:ENVI) alleging that Envivio misled investors in connection with the...
Helix BioPharma Announces Appointment of Director
December 20, 2012 22:09 ET
|
Helix BioPharma Corp.
AURORA, ON--(Marketwire - Dec 20, 2012) - Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), a biopharmaceutical company developing drug candidates for the prevention and treatment of cancer, today...
- October 10, 2024 12:01 ET Christy Sports Announces Ready. Set. Snow! Its First Locals’ Appreciation Event
- October 10, 2024 12:00 ET Mortgage Rates Surge